- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Genpharmasec has announced that the funds raised from its Rights Issue, totaling Rs. 48.45 Cr, have been used entirely as disclosed in the original offer. For the quarter ending September 30, 2025, the company confirmed no deviation in the utilization of these proceeds. Key allocations include acquiring equity shares, repaying certain borrowings, funding working capital, and general corporate purposes. This update provides clarity to investors that the capital raised is being deployed precisely for its stated business objectives.